SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035313
Filing Date
2023-12-26
Accepted
2023-12-26 16:15:21
Documents
13
Period of Report
2023-12-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20231226_8k.htm   iXBRL 8-K 36181
  Complete submission text file 0001437749-23-035313.txt   184425

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231226.xsd EX-101.SCH 3892
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231226_def.xml EX-101.DEF 13444
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231226_lab.xml EX-101.LAB 17671
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231226_pre.xml EX-101.PRE 13421
7 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20231226_8k_htm.xml XML 4406
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231513485
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)